The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance.

MLA

Wang, Zhenxing, et al. “The Human DNA Topoisomerase I Mutant Gly717Asp: Higher Religation Rate Is Not Always Associated with Camptothecin Resistance.” Archives of Biochemistry and Biophysics, vol. 663, Mar. 2019, pp. 165–72. EBSCOhost, https://doi.org/10.1016/j.abb.2019.01.007.

APA

Wang, Z., D’Annessa, I., Tesauro, C., Ottaviani, A., Soren, B. C., Dasari, J. B., Messina, B., Thareparambil, A., & Fiorani, P. (2019). The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance. Archives of Biochemistry and Biophysics, 663, 165–172. https://doi.org/10.1016/j.abb.2019.01.007

Chicago

Wang, Zhenxing, Ilda D’Annessa, Cinzia Tesauro, Alessio Ottaviani, Bini Chhetri Soren, Jagadish Babu Dasari, Beatrice Messina, Anil Thareparambil, and Paola Fiorani. 2019. “The Human DNA Topoisomerase I Mutant Gly717Asp: Higher Religation Rate Is Not Always Associated with Camptothecin Resistance.” Archives of Biochemistry and Biophysics 663 (March): 165–72. doi:10.1016/j.abb.2019.01.007.